8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001493152-22-012876
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading form8-k.htm…